In the new study comparing two doses of CBD to a placebo, the researchers reported a 41.9 percent reduction in “drop seizures” — a type of seizure that results in severe loss of muscle control and balance — in patients taking a 20 mg/kg/d CBD regimen, a 37.2 percent reduction in those on a 10 […]

by

A new study published in the Lancet Neurology Journal has revealed that a drug made of cannabis is capable of treating motor neuron disease. A clinical trial conducted by scientists revealed that this cannabis-based drug helps to ease muscle movements of patients suffering from this disease. During the study, researchers found that delta-9 tetrahydrocannabinol THC […]

by

Treatment with cannabinoids improved muscle function in a mouse model of myasthenia gravis (MG), suggesting they may have therapeutic potential for the disease, researchers say. The study, “Cannabinoid-induced increase of quantal size and enhanced neuromuscular transmission,” appeared in the journal Scientific Reports. Cannabinoids regulate multiple levels of neuronal communication, including the formation of new neurons and the release […]

by

Current first-line therapies for Dravet syndrome have limited effectiveness, but treatment candidates now undergoing clinical testing show significant promise, researchers suggest in a recent review. The study, “Treatment Strategies for Dravet Syndrome,” was published in the journal CNS Drugs. Accurate diagnosis of Dravet syndrome is possible within the first two years of life, when the child […]

by

TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research, development and commercialization of novel cannabinoid-based products, today announced the introduction of RELICANN™, the Company’s hemp-based  and medical cannabis brand designed for the health and wellness […]

by

The US Food and Drug Administration (FDA) has issued a safety communication warning that GlaxoSmithKline’s lamotrigine (Lamictal) for seizures and bipolar disorder can cause hemophagocytic lymphohistiocytosis (HLH), a rare, but very serious immune system reaction that excessively activates the body’s infection-fighting immune system. As a result of the warning, the agency is requiring the prescribing […]

by

Christoph U. Correll, MD Monitoring patients from baseline throughout treatment, screening patients for tardive dyskinesia (TD) risk factors and using reliable diagnostic tools are key factors in identifying the disorder as early as possible, according to a new review. But understanding the risk factors in order to take steps to prevent TD is more valuable. […]

by

The US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for Novartis’ siponimod (BAF312) for secondary progressive multiple sclerosis. The investigational drug is an oral, once-daily medication for the treatment of the condition in adults. In addition to the NDA acceptance, a Marketing Authorization Application was accepted by the European Medicines […]

by

Like elsewhere in the health and nutrition industry, sports performance researchers are looking to cannabidiol (CBD) to uncover new athletic benefits. Science is also starting to look at how natural ingredients affect women specifically rather than the traditional “pink it and shrink it” approach. Steve Myers, senior editor, INSIDER, discusses these and other sports nutrition […]

by

GM saves 2,700 jobs General Motors’ plans to lay off 14,000 salaried and blue-collar workers might not be as bad as originally projected. The company said Friday that 2,700 out of the 3,300 U.S. factory jobs slated for elimination will now be saved. Blue-collar workers will still lose jobs at four U.S. plants slated for […]

by

Cannabidiol, also referred to as CBD, is a non-intoxicating compound found in cannabis. A purified form of cannabidiol has recently been licensed in the USA as a treatment for rare childhood epilepsies, and a 2017 King’s College London trial has demonstrated cannabidiol has anti-psychotic properties. However, exactly how cannabidiol may work in the brain to […]

by